Location: Home > Pharma China Web Edition
  • search
  • go
  • Product/R&D News
  • 3/2/2026China Approves Jaypirca for Expanded Blood Cancer Indications
  • 3/2/2026NMPA Approves Rovalicitinib for First-Line Myelofibrosis
  • 3/2/2026Innovent Registers Phase I Study for FIC Dual-Payload Bispecific ADC
  • 3/2/2026Sanofi Secures Two New China Approvals for Dupilumab
  • 2/27/2026CSPC Launches Phase III Program for SYH2053 PCSK9 siRNA in China
  • 2/27/2026Evopoint Biosciences Highlights Igermetostat Data at ASCO GU 2026 in m...
  • 2/26/2026BMS-Partnered Bispecific ADC Achieves Dual Survival Milestones in Chin...
  • 2/26/2026Health Guard's Trial Suspensions Deepen Pressure on China's HPV Vaccin...
  • 2/26/2026Jiuyuan Files for Approval of Wegovy Biosimilar in China
  • 2/26/2026Pfizer Updates Pneumococcal Vaccine Trial in China, Implications for I...
  • 2/25/2026CStone Secures UK Approval for Sugemalimab in Stage III NSCLC
  • 2/25/2026Kelun-Biotech's sac-TMT OS Data Selected as Late-Breaker at ELCC 2026
  • 2/24/2026Biokin's Iza-Bren Achieves Second Phase III Survival Success in China ...
  • 2/24/2026Huadong Launches Head-to-Head Phase III Trial for Dual GLP-1/GIP Agoni...
  • 2/24/2026GenSci Advances PD-1 Agonist Into Phase 2b for Rheumatoid Arthritis
  • 2/24/2026Ascentage Registers U.S. Phase 1 Trial for BTK PROTAC APG-3288
  • 2/24/2026United Labs and Novo Nordisk Post Strong Phase 2 Data for UBT251 Tripl...
  • 2/20/2026CSPC's Long-Acting SYH2082 Clears FDA to Begin Clinical Trials
  • 2/16/2026CSPC's Long-Acting Ropivacaine Injection Cleared for Clinical Trials i...
  • 2/16/2026CStone's Trispecific Antibody CS2009 Receives FDA IND Clearance, Ente...
  • 2/12/2026Ascletis Picks Oral Amylin Agonist ASC36 for Obesity Development, Plan...
  • 2/12/2026RemeGen Advances PD-1/VEGF BsAb RC148 Into Phase 3 Trials
  • 2/12/2026Lilly's Jaypirca Approved in China for Previously Treated CLL and SLL ...
  • 2/12/2026Lilly China's Mounjaro Approved for Type 2 Diabetes Monotherapy
  • 2/11/2026Eli Lilly's Omvoh Approved in China for Crohn's Disease and Ulcerative...
  • 2/11/2026Betta Pharma Wins China Approval for Pertuzumab Biosimilar in Breast C...
  • 2/11/2026Shiling Pharma Targets 2028 for Nasal Spray Version of Wegovy Obesity ...
  • 2/11/2026China Eyes Approval for Russian Cancer Vaccine 'Enteromix'
  • 2/11/2026GSK's RSV Vaccine Arexvy Moves Forward in China
  • 2/10/2026Weekly China Regulatory Roundup: EGFR, TROP2 Approvals and Broad IND A...
  • Page:1/22 Total number of articles:645: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group